Ekso Bionics at a Glance:
-The Ekso Bionics Ekso GT™ is the first exoskeleton approved for stroke rehabiliation -Initially targeting an addressable medical market of over $1 billion
CEO is Thomas Looby -Over 190 international patent cases (granted or pending)
-Over $60M invested in technology to date, incl $35M in grants and NRE
~100 employees, including some in Europe
-Originally Berkely Bionics of Univsity of California, Berkeley
Company Presentation: http://content.equisolve.net/eksobionics/media/1fb1a2001e9fe48c8dcbdf9c96f59780.pdf
-Company committed to applying the latest technology and engineering to rethink current physical limitations *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum. Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-Highly advanced, proprietary actuator, motion control, battery and other robotics technologies that can change the face of medical, industrial, aerospace and military technologies
-Partnerships with world-class institutions such as Lockheed Martin Corporation, the Department of Defense, SOCOM
-Multiple centers testing the device, including the Kessler Foundation, a global leader in rehabilitation research ~190 units of Ekso™ model sold since February 2012
> 125 Customers, > 20 Multi-unit customers
• There are no guarantees when buying or selling any security.